Wnt/β-Catenin signaling pathway is a direct enhancer of thyroid transcription Factor-1 in human papillary thyroid carcinoma cells

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Gilbert Sirieix, Marie ^a   Makoukji, Joelle ^b   Kimura, Shioko ^c   Talbot, Monique ^a   Caillou, Bernard ^a   Massaad, Charbel ^b   Massaad Massade, Liliane ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; LITHIUM CHLORIDE; LYMPHOID ENHANCER FACTOR; SMALL INTERFERING RNA; T CELL FACTOR PROTEIN; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WNT PROTEIN; DNA BINDING PROTEIN; LUCIFERASE; MESSENGER RNA; TTF1 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; THYROID PAPILLARY CARCINOMA; TRANSCRIPTION REGULATION; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; ENHANCER REGION; ENZYME IMMUNOASSAY; GENETICS; METABOLISM; PAPILLARY CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID TUMOR; TUMOR CELL CULTURE; WESTERN BLOTTING; WNT SIGNALING PATHWAY;

BETA CATENIN; BLOTTING, WESTERN; CARCINOMA, PAPILLARY; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; ENHANCER ELEMENTS, GENETIC; HUMANS; IMMUNOENZYME TECHNIQUES; LITHIUM CHLORIDE; LUCIFERASES; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TCF TRANSCRIPTION FACTORS; THYROID NEOPLASMS; TUMOR CELLS, CULTURED; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 79960626850     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022280     Document Type: Article

References (44)

1. Ito Y, Miyauchi A, (2009) Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid. Endocr J 56: 177-192.
2. Schlumberger M, (2007) Cancer papillaire et folliculaire de la thyroïde. In: Orphanet E, editors. Annales d'endocrinologie.
3. Veliz J, Brantes S, Ramos C, Aguayo J, Caceres E, et al. (2008) [Thyroglobulin levels in needle lymph node cytology for the detection of papillary thyroid cancer recurrence]. Rev Med Chil 136: 1107-1112.
4. Civitareale D, Lonigro R, Sinclair AJ, Di Lauro R, (1989) A thyroid-specific nuclear protein essential for tissue-specific expression of the thyroglobulin promoter. Embo J 8: 2537-2542.
5. Rosai J, (2003) Immunohistochemical markers of thyroid tumors: significance and diagnostic applications. Tumori 89: 517-519.
6. Lin JD, (2008) Thyroglobulin and human thyroid cancer. Clin Chim Acta 388: 15-21.
7. Guazzi S, Price M, De Felice M, Damante G, Mattei MG, et al. (1990) Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. Embo J 9: 3631-3639.
8. Ordonez NG, (2000) Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas. Adv Anat Pathol 7: 123-127.
9. Srodon M, Westra WH, (2002) Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases. Hum Pathol 33: 642-645.
10. Roh MS, Hong SH, (2002) Utility of thyroid transcription factor-1 and cytokeratin 20 in identifying the origin of metastatic carcinomas of cervical lymph nodes. J Korean Med Sci 17: 512-517.
11. Cai YC, Banner B, Glickman J, Odze RD, (2001) Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Hum Pathol 32: 1087-1093.
12. Oliveira AM, Tazelaar HD, Myers JL, Erickson LA, Lloyd RV, (2001) Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites. Am J Surg Pathol 25: 815-819.
13. Fabbro D, Di Loreto C, Beltrami CA, Belfiore A, Di Lauro R, et al. (1994) Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms. Cancer Res 54: 4744-4749.
14. Ziad el A, Ruchala M, Breborowicz J, Gembicki M, Sowinski J, et al. (2008) Immunoexpression of TTF-1 and Ki-67 in a coexistent anaplastic and follicular thyroid cancer with rare long-life surviving. Folia Histochem Cytobiol 46: 461-464.
15. Fenton CL, Patel A, Burch HB, Tuttle RM, Francis GL, (2001) Nuclear localization of thyroid transcription factor-1 correlates with serum thyrotropin activity and may be increased in differentiated thyroid carcinomas with aggressive clinical course. Ann Clin Lab Sci 31: 245-252.
16. Garcia-Jimenez C, Santisteban P, (2007) TSH signalling and cancer. Arq Bras Endocrinol Metabol 51: 654-671.
17. MacDonald BT, Tamai K, He X, (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9-26.
18. Kim WB, Lewis CJ, McCall KD, Malgor R, Kohn AD, et al. (2007) Overexpression of Wnt-1 in thyrocytes enhances cellular growth but suppresses transcription of the thyroperoxidase gene via different signaling mechanisms. J Endocrinol 193: 93-106.
19. Chen G, Jiang Q, You Z, Yao J, Mou L, et al. (2009) Regulation of GSK-3 beta in the proliferation and apoptosis of human thyrocytes investigated using a GSK-3 beta-targeting RNAi adenovirus expression vector: involvement the Wnt/beta-catenin pathway. Mol Biol Rep 37: 2773-2779.
20. Nakatani Y, Masudo K, Miyagi Y, Inayama Y, Kawano N, et al. (2002) Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules. Mod Pathol 15: 617-624.
21. Ishigaki K, Namba H, Nakashima M, Nakayama T, Mitsutake N, et al. (2002) Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer. J Clin Endocrinol Metab 87: 3433-3440.
22. Rao AS, Kremenevskaja N, Resch J, Brabant G, (2005) Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling. Eur J Endocrinol 153: 929-938.
23. Lantsov D, Meirmanov S, Nakashima M, Kondo H, Saenko V, et al. (2005) Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression. Histopathology 47: 248-256.
24. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, et al. (1998) Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512.
25. Tetsu O, McCormick F, (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426.
26. Takahashi M, Tsunoda T, Seiki M, Nakamura Y, Furukawa Y, (2002) Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers. Oncogene 21: 5861-5867.
27. Schwartz DR, Wu R, Kardia SL, Levin AM, Huang CC, et al. (2003) Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas. Cancer Res 63: 2913-2922.
28. Hussein SM, Duff EK, Sirard C, (2003) Smad4 and beta-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2. J Biol Chem 278: 48805-48814.
29. Abbosh PH, Nephew KP, (2005) Multiple signaling pathways converge on beta-catenin in thyroid cancer. Thyroid 15: 551-561.
30. Rao AS, Kremenevskaja N, von Wasielewski R, Jakubcakova V, Kant S, et al. (2006) Wnt/beta-catenin signaling mediates antineoplastic effects of imatinib mesylate (gleevec) in anaplastic thyroid cancer. J Clin Endocrinol Metab 91: 159-168.
31. Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, et al. (2008) Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab 93: 4331-4341.
32. Kondo T, Nakazawa T, Ma D, Niu D, Mochizuki K, et al. (2009) Epigenetic silencing of TTF-1/NKX2-1 through DNA hypermethylation and histone H3 modulation in thyroid carcinomas. Lab Invest 89: 791-799.
33. Meireles AM, Preto A, Rocha AS, Rebocho AP, Maximo V, et al. (2007) Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines. Thyroid 17: 707-715.
34. van Staveren WC, Solis DW, Delys L, Duprez L, Andry G, et al. (2007) Human thyroid tumor cell lines derived from different tumor types present a common dedifferentiated phenotype. Cancer Res 67: 8113-8120.
35. Ricarte-Filho JC, Fuziwara CS, Yamashita AS, Rezende E, da-Silva MJ, et al. (2009) Effects of let-7 microRNA on Cell Growth and Differentiation of Papillary Thyroid Cancer. Transl Oncol 2: 236-241.
36. Pilli T, Prasad KV, Jayarama S, Pacini F, Prabhakar BS, (2009) Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer. Thyroid 19: 1333-1342.
37. Hedgepeth CM, Conrad LJ, Zhang J, Huang HC, Lee VM, et al. (1997) Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev Biol 185: 82-91.
38. Klein PS, Melton DA, (1996) A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A 93: 8455-8459.
39. Kunnimalaiyaan M, Vaccaro AM, Ndiaye MA, Chen H, (2007) Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells. Mol Cancer Ther 6: 1151-1158.
40. Adler JT, Hottinger DG, Kunnimalaiyaan M, Chen H, Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride. J Surg Res 159: 640-644.
41. Seifeddine R, Dreiem A, Blanc E, Fulchignoni-Lataud MC, Le Frere Belda MA, et al. (2008) Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells. Cancer Res 68: 2158-2165.
42. Oguchi H, Kimura S, (1998) Multiple transcripts encoded by the thyroid-specific enhancer-binding protein (T/EBP)/thyroid-specific transcription factor-1 (TTF-1) gene: evidence of autoregulation. Endocrinology 139: 1999-2006.
43. Smith JC, Conlon FL, Saka Y, Tada M, (2000) Xwnt11 and the regulation of gastrulation in Xenopus. Philos Trans R Soc Lond B Biol Sci 355: 923-930.
44. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.